Tag: EndoCanna
-
![Heritage Cannabis (CANN.C) launches new consumer product as global cannabis stocks rally 61% in Q4, 2020]()
Heritage Cannabis (CANN.C) launches new consumer product as global cannabis stocks rally 61% in Q4, 2020
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers.
-
![Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus]()
Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”
-
Heritage Cannabis (CANN.C) is so close profitability, it’s breaking social distancing rules
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate revenue going forward.
-
Heritage Cannabis (CANN.C) to develop vape oil with Sugarbud’s biomass
Heritage is positioning itself to radically expand its sales territory.
-
Heritage Cannabis (CANN.C) acquires Opticann – to create an international medical footprint
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”.
-
![Heritage Cannabis’ (CANN.C) subsidiary Endocanna Health licenses DNA kits for Empower Clinics (CBDT.C)]()
Heritage Cannabis’ (CANN.C) subsidiary Endocanna Health licenses DNA kits for Empower Clinics (CBDT.C)
Endocanna Health, a subsidiary of Heritage Cannabis (CANN.C), has agreed to manufacture and license its patent-pending Endocannabinoid DNA Test Kits to Empower Clinics (CBDT.C). Imagine a product tuned in directly to your specific DNA to give you exactly what you need when you need it. That’s what Endocanna’s test kits offer. Endocanna’s kits provide personalized…
-
![Heritage Cannabis (CANN.C) acquires a 30% stake in EndoCanna]()
Heritage Cannabis (CANN.C) acquires a 30% stake in EndoCanna
Heritage Cannabis (CANN.C) is back in the headlines Wednesday after announcing plans to acquire a minority stake in EndoCanna, one of California’s leading DNA-testing marijuana companies. The news comes about a week after Equity Guru identified extracts and their derivatives as one of the final frontiers of the cannabis boom – in an article covering…
